MAURIZIO DE ANGELIS / SCIENCE PHOTO LIBRARY MAURIZIO DE ANGELIS / SCIENCE PHOTO LIBRARY
Cetuximab chemotherapy drug. This drug, marketed as Erbitux, is used to treat metastatic head and neck cancers spread from colorectal cancer. It is a monoclonal antibody that acts by inhibiting epidermal growth factor receptor (EGFR), therefore blocking the signals that tell the cancer cells to grow and divide.
Model release not required. Property release not required.